These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18379193)

  • 21. 11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
    Nanni C; Castellucci P; Farsad M; Rubello D; Fanti S
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1704-5. PubMed ID: 17619877
    [No Abstract]   [Full Text] [Related]  

  • 22. Tropane-derived (11) C-labelled and (18) F-labelled DAT ligands.
    Riss PJ; Stockhofe K; Roesch F
    J Labelled Comp Radiopharm; 2013; 56(3-4):149-58. PubMed ID: 24285320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local and metastatic tumor growth and membrane properties of LM fibroblasts in athymic (nude) mice.
    Kier AB; Parker MT; Schroeder F
    Biochim Biophys Acta; 1988 Mar; 938(3):434-46. PubMed ID: 2831981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions.
    Chiotellis A; Sladojevich F; Mu L; Müller Herde A; Valverde IE; Tolmachev V; Schibli R; Ametamey SM; Mindt TL
    Chem Commun (Camb); 2016 May; 52(36):6083-6. PubMed ID: 27043419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex.
    Wang H; Tang X; Tang G; Huang T; Liang X; Hu K; Deng H; Yi C; Shi X; Wu K
    Apoptosis; 2013 Aug; 18(8):1017-27. PubMed ID: 23613106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
    Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
    Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M
    J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy].
    Yoshimoto M
    Igaku Butsuri; 2015; 35(1):10-5. PubMed ID: 26753391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total choline at 1H-MRS and [18F]-fluoromethylcholine uptake at PET.
    Kwee S; Ernst T
    Mol Imaging Biol; 2010 Aug; 12(4):424-5; author reply 426. PubMed ID: 20458633
    [No Abstract]   [Full Text] [Related]  

  • 30. Choline transporter as a novel target for molecular imaging of cancer.
    Hara T; Bansal A; DeGrado TR
    Mol Imaging; 2006; 5(4):498-509. PubMed ID: 17150162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
    Koo PJ; David Crawford E
    Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy.
    De Giorgi U; Amadori D
    J Clin Oncol; 2010 May; 28(15):e236-7; author reply e238. PubMed ID: 20177016
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of trigger PSA and PSA kinetics on (11)C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
    Jadvar H
    J Nucl Med; 2010 Mar; 51(3):498-9; author reply 499-500. PubMed ID: 20150273
    [No Abstract]   [Full Text] [Related]  

  • 34. Beyond FDG: Many Molecular Imaging Agents Are in Development.
    Brower V
    J Natl Cancer Inst; 2011 Jan; 103(1):13-5. PubMed ID: 21169540
    [No Abstract]   [Full Text] [Related]  

  • 35. Standardization and quantification in PET/CT imaging: tracers beyond FDG.
    Antunovic L; Rodari M; Rossi P; Chiti A
    PET Clin; 2014 Jul; 9(3):259-66. PubMed ID: 25030389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorocholine PET/computed tomography: physiologic uptake, benign findings, and pitfalls.
    Beheshti M; Haroon A; Bomanji JB; Langsteger W
    PET Clin; 2014 Jul; 9(3):299-306. PubMed ID: 25030393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging.
    Hara T; Yuasa M
    Appl Radiat Isot; 1999 Mar; 50(3):531-3. PubMed ID: 10070713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [PET radiopharmaceuticals: novelties and new possibilities].
    Környei J; Mikecz P; Tóth G
    Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New trends and novel possibilities in functional medical imaging: imaging methods].
    Balkay L; Emri M; Krizsán KÁ; Opposits G; Varga J
    Magy Onkol; 2015 Mar; 59(1):4-9. PubMed ID: 25763907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion.
    Ambrosini V; Farsad M; Nanni C; Schiavina R; Rubello D; Castellucci P; Pasquini E; Franchi R; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1522. PubMed ID: 16896665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.